Tetsuo Ohnishi
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia.
Journal: Schizophrenia bulletin
Published: February 17, 2021
A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain.
Journal: Molecular psychiatry
Published: January 27, 2021
LDB2 locus disruption on 4p16.1 as a risk factor for schizophrenia and bipolar disorder.
Journal: Human genome variation
Published: July 13, 2020
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.
Journal: EBioMedicine
Published: July 02, 2020
Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia.
Journal: EMBO molecular medicine
Published: April 22, 2020
Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: April 02, 2020
Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis.
Journal: Journal of affective disorders
Published: January 07, 2020
A potential role of fatty acid binding protein 4 in the pathophysiology of autism spectrum disorder.
A potential role of fatty acid binding protein 4 in the pathophysiology of autism spectrum disorder.
Journal: Brain communications
Published: December 19, 2019
Enhanced carbonyl stress induces irreversible multimerization of CRMP2 in schizophrenia pathogenesis.
Journal: Life science alliance
Published: July 01, 2019
Investigation of betaine as a novel psychotherapeutic for schizophrenia.
Journal: EBioMedicine
Published: April 28, 2019
Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology.
Journal: EMBO molecular medicine
Published: April 01, 2019
Last Updated: 09/26/2026